Global Business
Novartis raises core profit outlook despite a sharp fall in reported earnings
Novartis improved its annual core operating profit forecast as priority medicines supported sales. Reported quarterly profit fell sharply, however, mainly because of an impairment linked to del-desiran. The results show a substantial difference between the company’s reported and adjusted performance.
এই খবরটি আপাতত ইংরেজিতে পড়ুন